The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

Health secretary Robert F. Kennedy Jr. has warned that children in the U.S. are being diagnosed with autism at an “alarming rate.” On Thursday, he promised to conduct exhaustive studies ...

Both of these aspects are acknowledged to exist on a spectrum both historically and by modern scientific consensus. This is because yeast feeds off of sugar. If your diabetes isn’t well ...

Some symptoms of diabetes, like increased hunger and thirst, can appear early, even before the condition is diagnosed. The symptoms of diabetes can appear fairly early, but you may not always ...

The government is set to increase its stake in Vodafone Idea to 48.99% by acquiring shares worth Rs 36,950 crore in exchange for spectrum auction dues. This move, following a relief package ...

Here's how the 2025 depth chart shapes up at this point, with more free agency additions still to come and 11 draft picks in the Ravens' possession. The Ravens invested more this offseason in ...

GREEN BAY, Wis. – With NFL free agency largely complete and the NFL Draft less than four weeks away, here are the Green Bay Packers’ unofficial depth charts. These are an estimation of how the ...

Semaglutide, the medication better known as Ozempic, reduces the symptoms of a condition that can lead to lower limb amputations in people with diabetes, according to a new study that reinforces ...

AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) agonist used to treat type 2 diabetes, obesity and cardiovascular disease, semaglutide ...